Stem (NYSE:STEM) Slips 12% In One Week Amid Financial Headwinds

Simply Wall St.
04 Apr

Stem (NYSE:STEM) recently appointed two seasoned directors to its board, highlighting efforts to strengthen its leadership. However, the company faced financial headwinds after reporting a substantial drop in revenue and an increased net loss for 2024, coupled with ambitious guidance for 2025. These financial challenges might have influenced last week's 11.89% decline in the stock price. The company's new partnership with Summit Ridge Energy could provide long-term benefits, yet the short-term market reaction remains subdued. This period coincided with broader market anxiety triggered by U.S. tariffs, affecting investor sentiment and technology stocks, contributing to Stem's decline.

Every company has risks, and we've spotted 3 weaknesses for Stem (of which 1 shouldn't be ignored!) you should know about.

NYSE:STEM Earnings Per Share Growth as at Apr 2025

We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Over the longer period of last year, Stem, Inc. experienced a total shareholder return decline of 83.05%. This performance starkly contrasted with the broader market and the US Electrical industry, which posted returns of 8.4% and 0.8%, respectively. The company's challenges began with Q2 2024, reporting a revenue drop from US$92.95 million to US$34 million and a net loss of US$582.27 million, including a significant goodwill impairment of US$547.15 million. Such financial strains were further evident in Q3 2024, with revenues falling to US$29.29 million alongside increasing losses.

Adding to its financial hurdles, Stem received a compliance notice from the NYSE in August 2024 due to its decreased share price. Although the company initiated a strategic review in mid-2024, the market's response has been less optimistic amid its unprofitability and substantial net losses culminating in a very large net loss of US$854.01 million for the financial year 2024. Despite projected revenue growth, these factors contributed to a volatile and declining share performance.

Take a closer look at Stem's potential here in our financial health report.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

If you're looking to trade Stem, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10